Acceleration Initiative Award supports researchers pursuing translational and preclinical pediatric cancer treatment research to overcome development barriers and reach clinical trials within three years.
Accelerating Hope: Clinical Trials for Hard-to-Treat Cancers Award supports researchers conducting clinical trials for hard-to-treat childhood cancers to advance safer, less toxic therapies.
Accelerator Awards support investigators pursuing ambitious four-year neuroendocrine cancer research to advance early detection, develop new therapies, and match treatments to individual tumor biology.
Alex's Lemonade Stand Foundation’s R Accelerated Award Grants support innovative research advancing safer, more effective therapies for childhood cancers.
Young Investigator Award supports early-career scientists pursuing innovative pediatric cancer research, including therapeutic target discovery, to advance better, safer treatments for children with cancer.
Catapult Award supports researchers conducting Phase 1 and Phase 2 pediatric cancer trials, moving promising laboratory findings into patient testing to advance better, less-toxic treatments for children.